Amlodipine Besylate Tablet
Product Images NDC 50090-5354

4 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 50090-5354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Besylate (Afcca25d 0e19 4800 A55d 1714067a4400 01)

Amlodipine Besylate (Afcca25d 0e19 4800 A55d 1714067a4400 01)
Chemical structure of the active ingredient Amlodipine Besylate, showing its detailed molecular configuration including functional groups and the besylate moiety.*
FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
Kaplan-Meier analysis chart comparing composite clinical outcomes for Amlodipine versus Placebo over 24 months. The graph plots event rate against time in months, showing separate curves for Amlodipine and Placebo, with numerical values for subjects at risk provided below the x-axis. Statistical results including P-value, Hazard Ratio, and 95% Confidence Interval are noted within the chart.*
FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
A forest plot chart presenting hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across patient subgroups, including overall population, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The x-axis ranges from 0 to 2, with a vertical dashed line at 1 indicating no effect. Each subgroup is represented by a square indicating hazard ratio and horizontal lines for confidence intervals.*
FDA Label Image

Label Image (Lbl500905354)

Label Image (Lbl500905354)
Amlodipine Besylate 10 mg oral tablets label from A-S Medication Solutions. The label includes the product number 5902-0, NDC 50090-5354-0, lot number, storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from light, and packaging information indicating a quantity of 30 tablets. The label also notes that each tablet contains an equivalent base amount of Amlodipine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.